InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,954.40
(
-0.17%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.75
(
0.25%
)
Bitcoin
57,592.39
(
-1.11%
)
Post# of 251670
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119535
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 204651

Tuesday, 11/20/2018 9:42:12 AM

Tuesday, November 20, 2018 9:42:12 AM

Post# of 251670
BSX acquires BTG.L for $4.24B in cash—a 37% premium:

https://www.wsj.com/articles/boston-scientific-acquires-u-k-s-btg-for-4-2-billion-1542713291

Boston Scientific said BTG’s interventional portfolio would boost its capabilities in areas such as cancer and pulmonary embolism… BTG’s PneumRx product, for example, is a tiny coil inserted into the lung’s airways to treat emphysema.

…Boston Scientific said it hadn’t yet decided what to do in the long term with BTG’s pharmaceuticals business, which is focused on antidote products and accounts for about a third of its total revenue. The biggest-selling product in that portfolio, CroFab, treats rattlesnake bites.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up